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Abstract
Ankaferd Blood Stopper (ABS) comprises a mixture of plants and stops bleeding via forming a protein network by erythroid
aggregation. Bleeding causes reduction of iron levels in body. It has been indicated that ABS contains significant amount of iron.
Thus, we investigated the biological activity of ABS-derived iron on iron-regulated genes during iron-deficiency anemia (IDA). IDA
We selected Caco-2 and HepG2 cell lines as in vitro models of human intestine and liver, respectively. Iron deficiency anemia was
induced by deferoxamine. The cells were treated with ferric ammonium citrate (FAC) and ABS. Messenger RNA levels of iron-
regulated genes were analyzed by quantitative reverse transcription polymerase chain reaction to elucidate whether iron in ABS
behaved similar to inorganic iron (FAC) during IDA. The results showed that ABS-derived iron influenced transcriptions of iron-
regulated marker genes, including divalent metal transporter (Dmt1), transferrin receptor (TfR), ankyrin repeat domain 37
(Ankrd37), and hepcidin (Hamp) in IDA-induced Caco-2 and HepG2 cells. Our results suggest that when ABS is used to stop tissue
bleeding, it might have an ability to reduce levels of IDA.
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Introduction
Ankaferd Blood Stopper (ABS) is commonly used to stop
bleeding of tissues.1,2 It has been shown that ABS reduces the
growth rate of pathogens indicating its protective effect against
microorganisms.3 Furthermore, ABS enhances bone cell
growth and regeneration in vivo.4,5 It also affects the levels
of transcription factors in human vessel endothelial cell
model.6 These studies indicate that ABS has effect on the phy-
siology of cells by influencing molecular and genetic mechan-
isms. It has been recently reported that ABS contains iron.7
Iron is one of the important transition metals in human and
involves in variety of physiological functions including oxygen
carrying, cell division, inflammation, and energy production.8
Consuming low levels of dietary iron or bleeding lead to iron-
deficiency anemia (IDA) in human, whereas high iron in human
body causes iron toxicity in tissues (hemochromatosis).8,9
Dietary iron absorption mainly occurs via enterocyte cells on
duodenum and upper jejunum of small intestine. Intestinal iron
absorption is essential to maintain iron balance in human body
because human does not have active excretion mechanism for
iron.10 Iron can be stored in liver or used by bone marrow to
make more red blood cells. Mature red blood cells can be
broken down by macrophages of spleen and iron is released
into blood circulation.8 Iron metabolism is tightly controlled by
the molecular and genetic mechanisms. Low iron (iron defi-
ciency) and hypoxia are 2 main physiological signals for intest-
inal iron absorption and iron metabolism.11 Iron deficiency leads
to induction of iron transporter genes and this is an important
adaptation of cell to absorb more dietary iron into the body.12,13
When iron demand is low, induction of iron-regulated genes can
reach normal physiological levels. Systemic iron level is con-
trolled by hepcidin protein (HAMP) that is secreted from the
liver. The HAMP leads to ferroportin 1 protein degradation
during elevated iron level in human body.14
The recent investigation has shown that ABS has significant
amount of iron.7 This observation let us hypothesize that iron in
ABS solution might have ability to reduce IDA. We tested this
idea in iron-deficiency-induced Caco-2 and HepG2 cell lines
by analyzing expression of iron-regulating genes. We showed
that iron in ABS solution was able to reduce IDA in vitro.
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Material and Methods
Cell Culture
Caco-2 cells were maintained in Eagle’s minimum essential
medium supplemented with 20% fetal bovine serum (FBS),
1% nonessential amino acids, 1% sodium pyruvate, and 1%
penicillin and streptomycin. Same medium mix was used for
HepG2 cells with 10% FBS. Cells were maintained and grown
in 5% CO2 incubator at 37
C. Passage numbers of the cells
were kept between 20 and 35. These cells have been commonly
used as an in vitro model in human intestine and liver iron
physiology.15,16 Experimental Caco-2 and HepG2 cells were
plated in 12 wells and grown for 21 and 5 days postconfluent,
respectively. Cell culture medium was changed every 2 days
until deferoxamine mesylate (DFO), ABS, and ferric ammo-
nium citrate (FAC) treatments were performed.
Iron Measurement From ABS
The ABS was provided by Dr Haznedaroglu (Department of
Hematology, Faculty of Medicine, Hacettepe University,
Ankara, Turkey). About 10 mL ABS was centrifuged at 100g
for 5 minutes. The ABS samples were utilized for acid diges-
tion, and atomic absorption spectroscopy was used to measure
iron levels in ABS solution.17
Induction of Iron Deficiency and Treatments of FAC
and ABS
Deferoxamine mesylate 100 mM was used for 24 hours to
induce IDA in both cell types. Cells were treated by 100 mg/
mL FAC, and FAC was used as control group for experimental
conditions to compare ABS-derived iron on genetic regulation
of cells. Both cell types were exposed to same amount of iron-
containing FAC and ABS solutions with same volume.
RNA Isolation and Quantitative Reverse Transcription
Polymerase Chain Reaction
RNA isolation was performed by RNAzol reagent (MRC Inc.,
OH, USA) according to the company’s instruction. Total
RNA sample 1 mg was used to make complementary DNA
synthesis (Life Technologies, California), and quantitative
reverse transcription polymerase chain reaction (RT-qPCR;
Life Technologies) was performed by following company
protocols. Gene-specific primers were used for iron- and
hypoxia-regulated genes (Table 1). Cyclophilin A1 (CypA1)
was chosen as a housekeeping gene to normalize the data. The
RT-qPCR data were converted to gene expression levels via
2DCt calculation methods.16
Statistical Analyses
All results were expressed as mean (standard deviation). One-
way analysis of variance with post hoc Tukey test was performed
for relative gene expression to compare experimental groups.
GraphPad Prism (version 6.0 forWindows; GraphPad. CA,USA)
was used to create all the figures and for statistical analysis.
Results
Iron level was measured 7.7 mg/mL in ABS solution. We did
not observe any dead cells due to ABS, FAC, and DFO treat-
ments in our experimental models. The DFO treatment signif-
icantly induced TfR and Dmt1 messenger RNA (mRNA)
expression levels in Caco-2 cells (Figure 1A and B). The DFO
increased TfR mRNA level in HepG2 cells; however, Dmt1
mRNA level was not affected by DFO treatment (Figure 1C
and D). Both cells were treated with ABS in order to under-
stand whether the effect of iron in ABS solution decreased
mRNA expression levels of these genes. We found that ABS
significantly reduced TfR and Dmt1 mRNA induction in Caco-
2 cells (Figure 1A and B). Moreover, ABS also reduced TfR
mRNA induction and the basal level of Dmt1 mRNA level in
HepG2 cells (Figure 1C and D). Ferric ammonium citrate treat-
ment showed very similar results that we observed from ABS
treatment in terms of TfR and Dmt1 mRNA regulation in both
cell lines under DFO-induced IDA (Figure 1). However, ABS
significantly reduced basal level of Dmt1 mRNA relative to
FAC treatment in HepG2 cells (Figure 1D). Next, possible role
of ABS on iron-deficiency-induced hypoxia was studied by
measuring mRNA level of hypoxia-regulating Ankrd37
gene.16,18 The DFO treatment significantly increased Ankrd37
mRNA expression in Caco-2 and HepG2 cells. Both FAC and
ABS decreased induction of Ankrd37 transcription (Figure 2A
and B). Iron is an important nutrient for Hamp gene regulation
in liver, and HAMP protein is a key systemic regulator for iron
metabolism in human.14 Thus, we tested whether FAC and
ABS had effect on Hamp gene regulation with or without
DFO-induced IDA in HepG2 cell. Results indicated that FAC
and ABS treatments significantly reduced Hamp gene mRNA
expression, and this reduction inHampmRNA was reversed by
DFO (Figure 3). Moreover, DFO treatment did not affectHamp
mRNA regulation in HepG2 cells.
Discussion
In vitro and in vivo ABS-related studies including bleeding,19
different types of cancer,20 wound healing,21 and inflammation
Table 1. Primer List
Gene Forward (50 to 30) Reverse (50 to 30)
CypA1 TACGGGTCCTGGC
ATCTTG
CGAGTTGTCCACA
GTCAGCA
Dmt1 TGCATCTTGCTGA
AGTATGTCACC
CTCCACCATCAGC
CACAGGAT
TfR TCAGAGCGTCGG
GATGATATCGG
CTTGATCCATCATC
ATTCTGAACTGCC
Ankrd37 AGCAGTCGCCTGT
CCACTTAGC
AGCAGGCTTAGGC
ACTCCAGG
Hamp AGTGGGACAGCCA
GACAGACG
CAGCTCTGCAAGTT
GTCCCGT
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are of great interest.22 The ABS has ability to form imperme-
able contact between red blood cells via modulation of ankyrin,
spectrin, and actin proteins with fibrinogen gamma.23 It has
been purposed that iron can bind to fibrinogen and this interac-
tion might play a role in the function of ABS on tissue bleed-
ing.24 Recently, Akar et al indicated that ABS had significant
amount of iron and very low concentration of copper and zinc.7
Thus, we investigated whether ABS-derived iron can ameliorate
DFO-induced iron deficiency in vitro. We used human Caco-2
and HepG2 cell lines as models of this study. After Caco-2 cells
are grown at 21 days postconfluent, they show physiological
similarities with human enterocyte cells.16 Enterocyte cells of
intestine are main contributor to arrange iron balance in human.
Moreover, liver is also important for iron homeostasis in terms
of iron storage.10 TfR and Dmt1 are used as marker genes to
evaluate whether ABS-derived iron reduced effect of IDA. TfR
and Dmt1 are very responsive to iron deficiency in vitro and in
vivo.13,16 Results indicated that DFO significantly increased
mRNA levels of TfR and Dmt1 genes, and this induction was
reversed by FAC and ABS. However, DFO did not have an
effect on Dmt1 mRNA levels in HepG2 cells. This result was
consistent with the literature.25 This might be related to liver iron
metabolism during anemia, because transferrin-transferrin
receptor (TFR)-dependent endocytosis is one of the main mole-
cular mechanisms for iron absorption during anemia in liver.26
Induction of TfR genes in this study might explain TFR-
dependent regulation of iron uptake in HepG2 cells.
It has been recently shown that hypoxia is a key molecular
signal for iron metabolism.11 Iron deficiency causes cellular
hypoxia via increasing protein stability of hypoxia inducible
factor 1a (HIF1a) and HIF2a transcription factors due to inac-
tivation of HIF prolyl-hydroxylases (PHDs), but available iron
can reduce stability of HIF1a and HIF2a by activation of PHD
enzymes.27 Ankrd37 is one of the most sensitive genes that is
Figure 1. Messenger RNA levels of iron-regulated genes in Caco-2 and HepG2 cells. Total RNA was isolated from experimental groups
following quantitative reverse transcription polymerase chain reaction (RT-qPCR) which was performed to analyze iron-regulated gene
expression (Caco-2 cells: A and B; HepG2 cells: C and D). Different letters show statistical significance between groups within each panel.
Letters depict mean (standard deviation); n ¼ 4 independent experiments, P  .05. TfR indicates transferrin receptor; Dmt1, divalent mineral
transporter 1.
962 Clinical and Applied Thrombosis/Hemostasis 24(6)
regulated by hypoxia.16,18 Thus, Ankrd37 was used as a genetic
marker for hypoxia in the current study. Data showed that DFO
induced transcription of Ankrd37 gene, whereas FAC and ABS
decreased induction of this gene. These results suggest that
ABS-derived iron has ability to reduce iron-deficiency-
induced hypoxia in both cell lines. Next, the effect of ABS-
derived iron was investigated on transcriptional regulation of
Hamp gene in HepG2 cells. It has been indicated that increased
levels of iron in blood leads to induction of Hamp gene.28
Surprisingly, both FAC and ABS reduced Hamp mRNA
expression without anemia. It has been indicated that Hamp
mRNA expression was suppressed by iron loading in HepG2
cells,29,30 and this is consistent with the current data. It was
suggested that systemic factor(s) was required for in vitro reg-
ulation of Hamp gene.30,31 The ABS-related studies have been
dramatically increased in different scientific areas. Possible
effects of iron in ABS should consider non-iron-related studies
because iron has a significant effect on gene regulation in vitro
and in vivo.13,16,32 Thus, ABS-derived iron might be a contri-
butor to molecular and genetic studies.
Conclusion
Our results showed that FAC and ABS had very similar effects
on gene regulation of anemic Caco-2 and HepG2 cells. This
suggests that ABS-derived iron is biologically active to reduce
IDA. It has been indicated that plant-based molecules can
reduce bioavailability and biofunctionality of iron.9 Our results
showed that plant-based molecules in ABS did not interfere
with the function of iron in cells. ABS-derived iron might help
to decrease anemia by providing iron when ABS stops tissue
bleeding. This is the first in vitro study to investigate the effect
of ABS on anemia. However, animal and human studies are
necessary to clarify the effect of ABS-derived iron on IDA.
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Figure 2. Effect of ABS on hypoxia-regulated Ankrd37 gene in Caco-2 and HepG2 cells. Ankrd37 is an iron-regulated hypoxic gene and mRNA
levels of Ankrd37 were analyzed by RT-qPCR (Caco-2 cells: A; HepG2 cells: B). Different letters show statistical significance between groups
within each panel. Letters depict mean (standard deviation); n ¼ 4 independent experiments, P  .05. Ankrd37 indicates ankyrin repeat domain
37; ABS, Ankaferd Blood Stopper; RT-qPCR, quantitative reverse transcription polymerase chain reaction.
Figure 3. Regulation of Hamp gene by ABS with or without iron-
deficiency anemia. Hepcidin is small peptide that controls intestinal
iron absorption and is produced by the liver. HampmRNA levels were
determined by RT-qPCR. Different letters show statistical significance
between groups within each panel. Letters depict mean (standard
deviation); n ¼ 4 independent experiments, P  .05. Hamp indicates
hepcidin; ABS, Ankaferd Blood Stopper; RT-qPCR, quantitative
reverse transcription polymerase chain reaction; HAMP, hepcidin
protein.
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